Cargando…
Tailoring neoadjuvant chemotherapy for patients with breast cancer who have achieved pathologic complete response
BACKGROUND: We retrospectively examined whether different cycles of chemotherapy affected the prognosis of patients who achieved a pathologic complete response (pCR). METHODS: We reviewed data from patients who achieved pCR after neoadjuvant chemotherapy (NACT) between 2008 and 2018. In total, 286 p...
Autores principales: | Li, Xianjun, Liu, Yang, Shan, Ming, Xu, Bingqi, Lu, Yubo, Zhang, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798334/ https://www.ncbi.nlm.nih.gov/pubmed/35117465 http://dx.doi.org/10.21037/tcr.2020.01.01 |
Ejemplares similares
-
Clinical and Therapeutic Factors Vary by Prognosis in Patients with Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer
por: Huang, Zhenfeng, et al.
Publicado: (2021) -
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
por: Acevedo, Francisco, et al.
Publicado: (2022) -
Better overall survival in patients who achieve pathological complete response after neoadjuvant chemotherapy for breast cancer in a Chilean public hospital
por: Acevedo, Francisco, et al.
Publicado: (2021) -
Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Xie, Li-Yun, et al.
Publicado: (2022) -
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
por: Chen, Sheng, et al.
Publicado: (2015)